Laryngeal Carcinoma

JM Henk

Hong Kong J Radiol 2001;4:119-21

The management of laryngeal cancer is reviewed in the context of the Clinical Practice Guidelines of the Coordination Committee in Clinical Oncology of the Hospital Authority. The relative merits of surgery and radiotherapy for various tumour stages is discussed. Chemotherapy has not yet been shown to have a clear place in management, even for ‘organ preservation’. Conventional fractionation of radiotherapy with 2 Gy/day for 5 days/week is no longer considered optimal; the Danish head and neck cancer regimen giving 6 fractions/week is suggested as an alternative standard.